These Include: Reduced Appetite: By regulating appetite, GLP-1 injections help you feel full longer, reducing the likelihood of overeating
Compare Semaglutide and Tirzepatide
Reducing alcohol intakeor cutting it out altogethercan lead to a noticeable decrease in belly fat
In 2021, the European Society of Cardiology (ESC) proposed a CVD risk prediction model, SCORE2, to identify individuals at risk of CVD and guide clinical decisions for these individuals [72], which was recently updated to SCORE2-Diabetes, taking into account geographical variations of CVD risk associated with T2DM [71, 72]
When people with Type 2 Diabetes use Semaglutide for about three months, they often lose around 5% of their body weight and their A1c levels can drop by about 0.8%